{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T04:12:47Z","timestamp":1794370367795,"version":"4.9.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T00:00:00Z","timestamp":1570665600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T00:00:00Z","timestamp":1570665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The current leading Zika vaccine candidates in clinical testing are based on live or killed virus platforms, which have safety issues, especially in pregnant women. Zika subunit vaccines, however, have shown poor performance in preclinical studies, most likely because the antigens tested do not display critical quaternary structure epitopes present on Zika E protein homodimers that cover the surface of the virus. Here, we produce stable recombinant E protein homodimers that are recognized by strongly neutralizing Zika specific monoclonal antibodies. In mice, the dimeric antigen stimulate strongly neutralizing antibodies that target epitopes that are similar to epitopes recognized by human antibodies following natural Zika virus infection. The monomer antigen stimulates low levels of E-domain III targeting neutralizing antibodies. In a Zika challenge model, only E dimer antigen stimulates protective antibodies, not the monomer. These results highlight the importance of mimicking the highly structured flavivirus surface when designing subunit vaccines.<\/jats:p>","DOI":"10.1038\/s41467-019-12677-6","type":"journal-article","created":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T06:32:32Z","timestamp":1570689152000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Oligomeric state of the ZIKV E protein defines protective immune responses"],"prefix":"10.1038","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9249-2844","authenticated-orcid":false,"given":"Stefan W.","family":"Metz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashlie","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Brackbill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Forsberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Miley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesar A.","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8649-4579","authenticated-orcid":false,"given":"Helen M.","family":"Lazear","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaomin","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aravinda M.","family":"de Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,10]]},"reference":[{"key":"12677_CR1","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/978-981-10-8727-1_5","volume":"1062","author":"EN Gallichotte","year":"2018","unstructured":"Gallichotte, E. N., Baric, R. S. & de Silva, A. M. The molecular specificity of the human antibody response to dengue virus infections. Adv. Exp. Med. Biol. 1062, 63\u201376 (2018).","journal-title":"Adv. Exp. Med. Biol."},{"key":"12677_CR2","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/nature18952","volume":"536","author":"RA Larocca","year":"2016","unstructured":"Larocca, R. A. et al. Vaccine protection against Zika virus from Brazil. Nature 536, 474\u2013478 (2016).","journal-title":"Nature"},{"key":"12677_CR3","doi-asserted-by":"publisher","first-page":"8085","DOI":"10.1016\/j.vaccine.2010.10.004","volume":"28","author":"OK Block","year":"2010","unstructured":"Block, O. K. et al. A tetravalent recombinant dengue domain III protein vaccine stimulates neutralizing and enhancing antibodies in mice. Vaccine 28, 8085\u20138094 (2010).","journal-title":"Vaccine"},{"key":"12677_CR4","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1128\/JVI.01826-10","volume":"85","author":"CM Midgley","year":"2011","unstructured":"Midgley, C. M. et al. An in-depth analysis of original antigenic sin in dengue virus infection. J. Virol. 85, 410\u2013421 (2011).","journal-title":"J. Virol."},{"key":"12677_CR5","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.virol.2012.03.003","volume":"429","author":"KL Williams","year":"2012","unstructured":"Williams, K. L., Wahala, W. M., Orozco, S., de Silva, A. M. & Harris, E. Antibodies targeting dengue virus envelope domain III are not required for serotype-specific protection or prevention of enhancement in vivo. Virology 429, 12\u201320 (2012).","journal-title":"Virology"},{"key":"12677_CR6","first-page":"77","volume":"5","author":"Y Liu","year":"2016","unstructured":"Liu, Y., Liu, J. & Cheng, G. Vaccines and immunization strategies for dengue prevention. Emerg. Microbes Infect. 5, 77\u201383 (2016).","journal-title":"Emerg. Microbes Infect."},{"key":"12677_CR7","doi-asserted-by":"publisher","first-page":"7439","DOI":"10.1073\/pnas.1200566109","volume":"109","author":"R de Alwis","year":"2012","unstructured":"de Alwis, R. et al. Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions. Proc. Natl Acad. Sci. USA 109, 7439\u20137444 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"12677_CR8","doi-asserted-by":"crossref","first-page":"5816","DOI":"10.1128\/jvi.69.9.5816-5820.1995","volume":"69","author":"SL Allison","year":"1995","unstructured":"Allison, S. L., Stadler, K., Mandl, C. W., Kunz, C. & Heinz, F. X. Synthesis and secretion of recombinant tick-borne encephalitis virus protein E in soluble and particulate form. J. Virol. 69, 5816\u20135820 (1995).","journal-title":"J. Virol."},{"key":"12677_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-01097-5","volume":"7","author":"JL Slon Campos","year":"2017","unstructured":"Slon Campos, J. L. et al. Temperature-dependent folding allows stable dimerization of secretory and virus-associated E proteins of Dengue and Zika viruses in mammalian cells. Sci. Rep. 7, 966 (2017).","journal-title":"Sci. Rep."},{"key":"12677_CR10","doi-asserted-by":"publisher","first-page":"15411","DOI":"10.1038\/ncomms15411","volume":"8","author":"A Rouvinski","year":"2017","unstructured":"Rouvinski, A. et al. Covalently linked dengue virus envelope glycoprotein dimers reduce exposure of the immunodominant fusion loop epitope. Nat. Commun. 8, 15411 (2017).","journal-title":"Nat. Commun."},{"key":"12677_CR11","doi-asserted-by":"publisher","first-page":"e1000821","DOI":"10.1371\/journal.ppat.1000821","volume":"6","author":"WM Wahala","year":"2010","unstructured":"Wahala, W. M. et al. Natural strain variation and antibody neutralization of dengue serotype 3 viruses. PLoS Pathog. 6, e1000821 (2010).","journal-title":"PLoS Pathog."},{"key":"12677_CR12","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1099\/vir.0.070813-0","volume":"96","author":"TJ Pitcher","year":"2015","unstructured":"Pitcher, T. J. et al. Functional analysis of dengue virus (DENV) type 2 envelope protein domain 3 type-specific and DENV complex-reactive critical epitope residues. J. Gen. Virol. 96, 288\u2013293 (2015).","journal-title":"J. Gen. Virol."},{"key":"12677_CR13","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.virol.2013.01.022","volume":"439","author":"Y Zhou","year":"2013","unstructured":"Zhou, Y. et al. The mechanism of differential neutralization of dengue serotype 3 strains by monoclonal antibody 8A1. Virology 439, 57\u201364 (2013).","journal-title":"Virology"},{"key":"12677_CR14","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1126\/science.aaa8651","volume":"349","author":"G Fibriansah","year":"2015","unstructured":"Fibriansah, G. et al. DENGUE VIRUS. Cryo-EM structure of an antibody that neutralizes dengue virus type 2 by locking E protein dimers. Science 349, 88\u201391 (2015).","journal-title":"Science"},{"key":"12677_CR15","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1128\/mBio.01123-16","volume":"7","author":"JA Swanstrom","year":"2016","unstructured":"Swanstrom, J. A. et al. Dengue virus envelope dimer epitope monoclonal antibodies isolated from dengue patients are protective against Zika virus. mBio 7, 1123\u20131131 (2016).","journal-title":"mBio"},{"key":"12677_CR16","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/emmm.201303404","volume":"6","author":"G Fibriansah","year":"2014","unstructured":"Fibriansah, G. et al. A potent anti-dengue human antibody preferentially recognizes the conformation of E protein monomers assembled on the virus surface. EMBO Mol. Med. 6, 358\u2013371 (2014).","journal-title":"EMBO Mol. Med."},{"key":"12677_CR17","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/nature14130","volume":"520","author":"A Rouvinski","year":"2015","unstructured":"Rouvinski, A. et al. Recognition determinants of broadly neutralizing human antibodies against dengue viruses. Nature 520, 109\u2013113 (2015).","journal-title":"Nature"},{"key":"12677_CR18","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.1007\/s00253-018-8822-y","volume":"102","author":"H Fahimi","year":"2018","unstructured":"Fahimi, H., Mohammadipour, M., Haddad Kashani, H., Parvini, F. & Sadeghizadeh, M. Dengue viruses and promising envelope protein domain III-based vaccines. Appl. Micro. Biot. 102, 2977\u20132996 (2018).","journal-title":"Appl. Micro. Biot."},{"key":"12677_CR19","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1586\/erv.09.139","volume":"9","author":"MG Guzman","year":"2010","unstructured":"Guzman, M. G., Hermida, L., Bernardo, L., Ramirez, R. & Guillen, G. Domain III of the envelope protein as a dengue vaccine target. Expert Rev. Vaccines 9, 137\u2013147 (2010).","journal-title":"Expert Rev. Vaccines"},{"key":"12677_CR20","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.antiviral.2018.04.010","volume":"154","author":"P Qu","year":"2018","unstructured":"Qu, P. et al. Insect cell-produced recombinant protein subunit vaccines protect against Zika virus infection. Antivir. Res. 154, 97\u2013103 (2018).","journal-title":"Antivir. Res."},{"key":"12677_CR21","doi-asserted-by":"publisher","first-page":"4287","DOI":"10.1016\/j.vaccine.2017.04.052","volume":"35","author":"M Yang","year":"2017","unstructured":"Yang, M., Dent, M., Lai, H., Sun, H. & Chen, Q. Immunization of Zika virus envelope protein domain III induces specific and neutralizing immune responses against Zika virus. Vaccine 35, 4287\u20134294 (2017).","journal-title":"Vaccine"},{"key":"12677_CR22","doi-asserted-by":"publisher","first-page":"3749","DOI":"10.1371\/journal.pntd.0003749","volume":"9","author":"J Flipse","year":"2015","unstructured":"Flipse, J. & Smit, J. M. The complexity of a dengue vaccine: a review of the human antibody response. PLoS Negl. Trop. Dis. 9, 3749\u20133767 (2015).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"12677_CR23","doi-asserted-by":"publisher","unstructured":"Collins, M. H. et al. Human antibody response to Zika targets type-specific quaternary structure epitopes. JCI Insight 4 https:\/\/doi.org\/10.1172\/jci.insight.124588 (2019).","DOI":"10.1172\/jci.insight.124588"},{"key":"12677_CR24","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4149\/av_2016_01_3","volume":"60","author":"J Martin","year":"2016","unstructured":"Martin, J. & Hermida, L. Dengue vaccine: an update on recombinant subunit strategies. Acta virologica 60, 3\u201314 (2016).","journal-title":"Acta virologica"},{"key":"12677_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2180-13-194","volume":"13","author":"YY Luo","year":"2013","unstructured":"Luo, Y. Y. et al. Identification of a novel infection-enhancing epitope on dengue prM using a dengue cross-reacting monoclonal antibody. BMC Microbiol. 13, 194 (2013).","journal-title":"BMC Microbiol."},{"key":"12677_CR26","doi-asserted-by":"publisher","unstructured":"Baronti, C. et al. Complete coding sequence of zika virus from a French polynesia outbreak in 2013. Genome Announc. 2 https:\/\/doi.org\/10.1128\/genomeA.00500-14 (2014).","DOI":"10.1128\/genomeA.00500-14"},{"key":"12677_CR27","doi-asserted-by":"crossref","first-page":"15D 13 11","DOI":"10.1002\/9780471729259.mc15d03s31","volume":"31","author":"JD Brien","year":"2013","unstructured":"Brien, J. D., Lazear, H. M. & Diamond, M. S. Propagation, quantification, detection, and storage of West Nile virus. Curr. Protoc. Microbiol. 31, 15D 13 11\u201315D 13 18 (2013).","journal-title":"Curr. Protoc. Microbiol."},{"key":"12677_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-04767-6","volume":"7","author":"SW Metz","year":"2017","unstructured":"Metz, S. W. et al. In vitro assembly and stabilization of dengue and Zika virus envelope protein homo-dimers. Sci. Rep. 7, 4524 (2017).","journal-title":"Sci. Rep."},{"key":"12677_CR29","doi-asserted-by":"publisher","first-page":"162","DOI":"10.4269\/ajtmh.1985.34.162","volume":"34","author":"EA Henchal","year":"1985","unstructured":"Henchal, E. A., McCown, J. M., Burke, D. S., Seguin, M. C. & Brandt, W. E. Epitopic analysis of antigenic determinants on the surface of dengue-2 virions using monoclonal antibodies. Am. J. Trop. Med. Hyg. 34, 162\u2013169 (1985).","journal-title":"Am. J. Trop. Med. Hyg."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-12677-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-12677-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-12677-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T20:27:21Z","timestamp":1671222441000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-12677-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,10]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["12677"],"URL":"https:\/\/doi.org\/10.1038\/s41467-019-12677-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/674424","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,10]]},"assertion":[{"value":"10 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4606"}}